TrialJournal of cachexia, sarcopenia and muscle2024

Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design.

John D Groarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.